Meeting
2016 ASCO Annual Meeting
Development of a nationwide genomic screening network for squamous cell lung cancer in Japan (LC-SCRUM-Japan).
Authors
Tadasuke Shimokawaji
Yokohama City University Medical Center, Yokohama City, Japan
Tadasuke Shimokawaji , Eri Sugiyama , Shingo Matsumoto , Kiyotaka Yoh , Masato Shingyoji , Kadoaki Ohashi , Terufumi Kato , Hiromi Aono , Yuichiro Ohe , Shunichi Sugawara , Naoki Furuya , Hirofumi Nakazaki , Kageaki Taima , Hiroshi Watanabe , Taishi Harada , Tomohiro Sakamoto , Shinnosuke Ikemura , Katsuya Tsuchihara , Koichi Goto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9097)
DOI
10.1200/JCO.2016.34.15_suppl.9097
Abstract #
9097
Poster Bd #
420
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Clinical features of squamous cell lung cancer with targetable gene alterations in a nationwide genomic screening network in Japan (LC-SCRUM-Japan).
First Author: Eri Sugiyama
Poster
2019 ASCO Annual Meeting
Therapeutic and prognostic impacts of specific gene alterations for squamous cell lung cancer: A result of nationwide genome screening in Japan (LC-SCRUM-Japan).
First Author: Terufumi Kato
Poster
2018 ASCO Annual Meeting
Therapeutic and prognostic impact of genetic alterations identified in nationwide genome screening for squamous cell lung cancer (LC-SCRUM-Japan).
First Author: Tomohiro Sakamoto
Poster
2020 ASCO Virtual Scientific Program
Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K/AKT/mTOR pathway based on a large-scale nationwide genomic screening network in Japan (EAGLE-PAT/LC-SCRUM-Japan).
First Author: Hibiki Udagawa